Página 3 - Melhores Melanoma médicos - TOP-100 médicos

O Prof. Adjunto Nail Paksoy combina competência em oncologia com investigação em imunoterapia no Hospital Medipol Bahçelievler.

• Certificado pelo Conselho da ESMO em Oncologia Médica
• Sub-investigador em 8 ensaios clínicos internacionais de relevo
• Investigação publicada sobre melanoma e outros cancros
• Especialização em Oncologia Médica pela Universidade de Istambul

Especializado em cirurgia laparoscópica e bariátrica avançada na Universidade de Istambul – uma das principais instituições médicas da Turquia.

• Mais de 20 anos de experiência cirúrgica
• Formado em várias universidades de prestígio, incluindo Ondokuz Mayıs e a Universidade de Istambul
• Especializar-se em técnicas de cirurgia oncológica de cancro
• Concluir o treino avançado em cirurgia laparoscópica em 2010

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

A Dra. Inta Jaunalksne é especialista em viroterapia, uma abordagem imunológica de ponta para o tratamento do melanoma.

• Mais de 30 anos de experiência em imunologia
• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga
• Internato em Medicina Interna

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Prof. Dr. Önder SÜRGİT is a General Surgeon in the General Surgery Clinic. Working hours: 09:00–18:00. Core practice areas include laparoscopic surgery, cancer surgery, and bariatric surgery.

Graduated from Hacettepe Faculty of Medicine in 1995. Academic title: Professor. Served as Instructor Surgeon at ITEM (Advanced Medical Technologies Training Center). Held faculty roles at Turgut Özal University and Atılım University, Faculties of Medicine. Also worked at Ankara Medicana Hospital and Optimed Health Group. Foreign language: English.

O Dr. Erkan Karatas é especialista em cirurgias complexas de cabeça e pescoço, com ampla formação internacional na Europa e nos EUA.

• Formação em instituições de topo, incluindo a Universidade Estadual de Ohio e a Escola de Medicina de Hannover
• Membro de múltiplas associações de prestígio de otorrinolaringologia e cirurgia de cabeça e pescoço
• Foco especial em procedimentos de otologia e neurotologia
• Participar em programas internacionais de educação e formação médica

Especialista Sénior em Cancro da Pele no St John's Institute of Dermatology – formado nos melhores hospitais do Reino Unido e de Israel, especializado em melanoma.

• Especialização (Fellowship) no St John's Institute, um centro líder em cancro da pele
• Docência sobre temas de melanoma no King's College London
• Membro da European Academy of Dermatology and Venereology
• Especializar-se tanto no diagnóstico como no tratamento cirúrgico de cancros da pele

O Dr. Bar-Sela é o Vice-Chefe do Departamento de Oncologia do Rambam Medical Center.

• Liderar uma equipa especializada num grande hospital académico
• Concentrar-se no tratamento do melanoma
• Supervisionar programas de tratamento avançados para doentes oncológicos

O Dr. Michael Lotem chefia o Centro de Imunoterapia de Melanoma e Cancro no Hadassah Medical Center, sendo pioneiro em novos tratamentos para doentes com melanoma.

• Chefe do Centro de Imunoterapia de Melanoma e Cancro
• Especialização em imunoterapias inovadoras para o melanoma
• Liderança de uma equipa de clínicos e investigadores
• Foco na investigação translacional com impacto clínico imediato

O Dr. Jesus Soberino é especialista em imunoterapia de melanoma, tendo contribuído para ensaios fundamentais que revolucionaram o tratamento do melanoma com medicamentos como Pembrolizumab e Nivolumab.

• 14 anos de experiência em oncologia com foco em melanoma
• Membro da Unidade de Melanoma do Hospital Universitário Vall d'Hebron e VHIO
• Participação em ensaios clínicos que levaram a medicamentos aprovados pela FDA
• Especialização em tratamentos de imunoterapia para melanoma metastático

Especializada em radioterapia, a Dra. Zalmanova oferece tratamentos direcionados no Assuta Medical Center.

• Ser especialista em técnicas avançadas de radioterapia
• Personalizar os planos de tratamento para cada paciente
• Focar na precisão e no conforto do paciente

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

O Dr. Tepper lidera todo o Centro de Oncologia do proeminente Centro Médico Assuta de Israel, trazendo supervisão estratégica para casos complexos de melanoma.

• Médico-chefe e oncologista sênior com anos de experiência focada
• Especializar-se no manejo avançado de cancros de pele como o melanoma
• Prestar cuidados num grande rede de hospitais privados de alta tecnologia
• Trazer uma perspectiva de liderança para a criação de planos de tratamento personalizados